The sertraline versus electrical current therapy for treating depression clinical study (SELECT-TDCS): Results of the crossover and follow-up phases

Depression and Anxiety

Volumn 30, Issue 7, 2013, Pages 646-653

  Valiengo, Leandro ^a   Benseñor, Isabela Martins ^a   Goulart, Alessandra C ^a   De Oliveira, Janaina Farias ^a   Zanao, Tamires Araujo ^a   Boggio, Paulo Sérgio ^b   Lotufo, Paulo Andrade ^a   Fregni, Felipe ^a,c,d   Brunoni, André Russowsky ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b MACKENZIE PRESBYTERIAN UNIVERSITY   (Brazil)

^c and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

follow up study, clinical trial; Kaplan Meier analysis; major depressive disorder; refractory depression; transcranial direct current stimulation

Indexed keywords

DIAZEPAM; PLACEBO; SERTRALINE;

ADULT; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; ELECTRIC CURRENT; FEMALE; FOLLOW UP; HAMILTON SCALE; HEADACHE; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PREDICTOR VARIABLE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PRURITUS; SKIN REDNESS; SOMNOLENCE; SUICIDAL IDEATION; SUICIDE ATTEMPT; SURVIVAL RATE; TRANSCRANIAL DIRECT CURRENT STIMULATION; TREATMENT DURATION; TREATMENT RESISTANT DEPRESSION; TREATMENT RESPONSE;

FOLLOW-UP STUDY, CLINICAL TRIAL; KAPLAN-MEIER ANALYSIS; MAJOR DEPRESSIVE DISORDER; REFRACTORY DEPRESSION; TRANSCRANIAL DIRECT CURRENT STIMULATION;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; CROSS-OVER STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RECURRENCE; SERTRALINE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84879727617     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22079     Document Type: Article

References (33)

1. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163 (11): 1905-1917.
2. Nitsche MA, Paulus W,. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol 2000; 527 (Pt 3): 633-639.
3. Mayberg HS,. Positron emission tomography imaging in depression: a neural systems perspective. Neuroimaging Clin N Am 2003; 13 (4): 805-815.
4. Kalu UG, Sexton CE, Loo CK, Ebmeier KP,. Transcranial direct current stimulation in the treatment of major depression: a meta-analysis. Psychol Med 2012; 42 (9): 1-10.
5. Brunoni AR, Valiengo L, Baccaro A, et al. The Sertraline versus Electrical Current Therapy for Treating Depression Clinical Trial (SELECT TDCS): results from a factorial, randomized, controlled trial. JAMA Psychiatry 2013. [Epub ahead of print].
6. Brunoni AR, Valiengo L, Baccaro A, et al. Sertraline vs. Electrical Current Therapy for Treating Depression Clinical Trial-SELECT TDCS: design, rationale and objectives. Contemp Clin Trials 2011; 32 (1): 90-98.
7. Brunoni AR, Amadera J, Berbel B, et al. A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation. Int J Neuropsychopharmacol 2011; 14 (8): 1133-1145.
8. Brunoni AR, Ferrucci R, Fregni F, et al. Transcranial direct current stimulation for the treatment of major depressive disorder: a summary of preclinical, clinical and translational findings. Prog Neuropsychopharmacol Biol Psychiatry 2012; 39 (1): 9-16.
9. Ferrucci R, Bortolomasi M, Vergari M, et al. Transcranial direct current stimulation in severe, drug-resistant major depression. J Affect Disord 2009; 118 (1-3): 215-219.
10. Boggio PS, Rigonatti SP, Ribeiro RB, et al. A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression. Int J Neuropsychopharmacol 2008; 11 (2): 249-254.
11. Cohen RB, Boggio PS, Fregni F,. Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depression. Depress Anxiety 2009; 26 (7): 682-688.
12. Demirtas-Tatlidede A, Mechanic-Hamilton D, Press DZ, et al. An open-label, prospective study of repetitive transcranial magnetic stimulation (rTMS) in the long-term treatment of refractory depression: reproducibility and duration of the antidepressant effect in medication-free patients. J Clin Psychiatry 2008; 69 (6): 930-934.
13. Janicak PG, Nahas Z, Lisanby SH, et al. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimulation 2010; 3 (4): 187-199.
14. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. J Am Med Assoc 2001; 285 (10): 1299-1307.
15. Tew JD, Jr., Mulsant BH, Haskett RF, et al. Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment. Ann Clin Psychiatry 2007; 19 (1): 1-4.
16. Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 2006; 63 (12): 1337-1344.
17. Lisanby SH, Husain MM, Rosenquist PB, et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology 2009; 34 (2): 522-534.
18. Sackeim HA,. Continuation therapy following ECT: directions for future research. Psychopharmacol Bull 1994; 30 (3): 501-521.
19. Martin DM, Alonzo A, Ho KA, et al. Continuation transcranial direct current stimulation for the prevention of relapse in major depression. J Affect Disord 2013; 144 (3): 274-278.
20. Rush A, Trivedi M, Wisniewski S, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163 (11): 1905-1917.
21. Warden D, Rush AJ, Trivedi MH, et al. The STAR*D Project results: a comprehensive review of findings. Curr Psychiatry Rep 2007; 9 (6): 449-459.
22. Greden JF,. The burden of disease for treatment-resistant depression. J Clin Psychiatry 2001; 62 (Suppl 16): 26-31.
23. Williams N, Simpson AN, Simpson K, Nahas Z,. Relapse rates with long-term antidepressant drug therapy: a meta-analysis. Hum Psychopharmacol 2009; 24 (5): 401-408.
24. Robert P, Montgomery SA,. Citalopram in doses of 20-60 mg is effective in depression relapse prevention: a placebo-controlled 6 month study. Int Clin Psychopharmacol 1995; 10 (Suppl 1): 29-35.
25. Schmidt ME, Fava M, Robinson JM, Judge R,. The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder. J Clin Psychiatry 2000; 61 (11): 851-857.
26. Simon JS, Aguiar LM, Kunz NR, Lei D,. Extended-release venlafaxine in relapse prevention for patients with major depressive disorder. J Psychiatr Res 2004; 38 (3): 249-257.
27. Priori A, Hallett M, Rothwell JC,. Repetitive transcranial magnetic stimulation or transcranial direct current stimulation? Brain Stimul 2009; 2 (4): 241-245.
28. Mantovani A, Pavlicova M, Avery D, et al. Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression. Depress Anxiety 2012; 29 (10): 883-890.
29. Prien RF, Carpenter LL, Kupfer DJ,. The definition and operational criteria for treatment outcome of major depressive disorder. A review of the current research literature. Arch Gen Psychiatry 1991; 48 (9): 796-800.
30. McDonald WM, Durkalski V, Ball ER, et al. Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. Depress Anxiety 2011; 28 (11): 973-980.
31. Cohen RB, Brunoni AR, Boggio PS, Fregni F,. Clinical predictors associated with duration of repetitive transcranial magnetic stimulation treatment for remission in bipolar depression: a naturalistic study. J Nerv Ment Dis 2010; 198 (9): 679-681.
32. Brunoni AR, Valiengo L, Zanao T, et al. Manic psychosis after sertraline and transcranial direct-current stimulation. J Neuropsychiatry Clin Neurosci 2011; 23 (3): E4-E5.
33. Baccaro A, Brunoni AR, Bensenor iM, Fregni F,. Hypomanic episode in unipolar depression during transcranial direct current stimulation. Acta Neuropsychiatrica 2010; 22 (6): 316-318.